» Articles » PMID: 23396998

The Pathogenetic Enigma of Polycystic Ovary Syndrome

Overview
Journal J Ultrasound
Publisher Springer
Specialty Radiology
Date 2013 Feb 12
PMID 23396998
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is a complex disease with heterogeneous clinical and anatomical features that were first described in 1721 by Antonio Vallisneri. There is still a lack of consensus regarding the criteria to be used for diagnosis of PCOS. Transvaginal ultrasonography with Doppler studies of the ovarian and pelvic vasculature plays an important role in its diagnosis, but findings must be interpreted in light of the patient's symptoms and laboratory findings.

Citing Articles

Ovulation stigma and rupture of ovarian tunica albuginea in a patient with polycystic ovary syndrome (video).

Alhalabi N, Alhalabi M, Alsamawi S, Alhalabi M J Surg Case Rep. 2021; 2021(10):rjab482.

PMID: 34733475 PMC: 8560203. DOI: 10.1093/jscr/rjab482.


Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study.

Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T Nutrients. 2021; 13(10).

PMID: 34684666 PMC: 8538182. DOI: 10.3390/nu13103665.


IGF-1R and Leptin Expression Profile and the Effects of Metformin Treatment on Metabolic and Endocrine Parameters in PCOS Mice.

Prado Correia L, De Almeida B, de Jesus Simoes M, Haidar M, Berguio Vidotti D, Silva I Biomed Res Int. 2018; 2017:9058307.

PMID: 29430464 PMC: 5752987. DOI: 10.1155/2017/9058307.


The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome.

Qu J, Che Y, Xu P, Xia Y, Wu X, Wang Y Int J Fertil Steril. 2015; 8(4):373-8.

PMID: 25780518 PMC: 4355923. DOI: 10.22074/ijfs.2015.4176.

References
1.
Diamanti-Kandarakis E, Mitrakou A, Hennes M, Platanissiotis D, Kaklas N, Spina J . Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome. Metabolism. 1995; 44(4):525-31. DOI: 10.1016/0026-0495(95)90062-4. View

2.
Nestler J, Barlascini C, Matt D, Steingold K, Plymate S, CLORE J . Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1989; 68(6):1027-32. DOI: 10.1210/jcem-68-6-1027. View

3.
Franks S . Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 1989; 31(1):87-120. DOI: 10.1111/j.1365-2265.1989.tb00457.x. View

4.
Polson D, Adams J, Wadsworth J, Franks S . Polycystic ovaries--a common finding in normal women. Lancet. 1988; 1(8590):870-2. DOI: 10.1016/s0140-6736(88)91612-1. View

5.
Battaglia C, Artini P, Genazzani A, Sgherzi M, Salvatori M, Giulini S . Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol. 1996; 7(5):342-6. DOI: 10.1046/j.1469-0705.1996.07050342.x. View